Curasight reports preliminary data from Phase 1 trial in patients with high-grade gliomas

Abbisko Therapeutics reports US FDA acceptance of pimicotinib NDA

AbbVie licenses PD-1/VEGF bispecific antibody RC148 from RemeGen in multi-billion dollar oncology deal

Summit Therapeutics and GSK form collaboration to study ivonescimab combination therapy

Summit Therapeutics submits FDA application for ivonescimab in EGFR-mutated lung cancer

Phanes Therapeutics reports clinical data on spevatamig chemotherapy combination in frontline treatment of mPDAC

Acousia Therapeutics completes patient enrolment in Phase 2 trial of Bimokalner

ZYUS Life Sciences reports positive preliminary results from Phase 2a trial of Trichomylin softgel

DELFI Diagnostics names new chief financial officer

Arbele's ARB1002 receives US FDA Orphan Drug Designation

GSK reports positive phase III results for bepirovirsen in chronic hepatitis B

Day One completes Mersana acquisition to add rare cancer antibody drug conjugate

Cartography Biosciences partners with Pfizer to discover tumour-selective antigens

BostonGene and AstraZeneca collaborate to advance AI-driven oncology development

RedHill advances RHB-102 across GI indications